Franklin Resources
LXRX icon

Franklin Resources’s Lexicon Pharmaceuticals LXRX Stock Holding History

Franklin Resources’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-140,773
Closed -$1.77M – 1569
2013
Q4 		$1.77M Sell
140,773
-160,580
-53% -$2.55M ﹤0.01% 1283
2013
Q3 		$5M Sell
301,353
-93,386
-24% -$1.57M ﹤0.01% 1112
2013
Q2 		$6M Buy
+394,739
New +$6M ﹤0.01% 1045

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources's LXRX Position: Q1 2014 in Review

Franklin Resources sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2014, closing a stake of 140,773 shares — an estimated $1.77M sold.

Franklin Resources first reported a position in LXRX in Q2 2013 and held it in 3 quarters. The position peaked at $6M in Q2 2013. 103 funds tracked by Wall St. Rank hold LXRX as of Q1 2014.

  • Franklin Resources reported no remaining Lexicon Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Franklin Resources sold 140,773 Lexicon Pharmaceuticals shares in Q1 2014, an estimated $1.77M.
  • Franklin Resources first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • Franklin Resources's Lexicon Pharmaceuticals position peaked at $6M in Q2 2013.
  • 103 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2014.

Based on Franklin Resources's 13F filing for Q1 2014, filed 13 May 2014.